Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

CAR T Cell Therapy: A Game Changer in Cancer Treatment.

Almåsbak H, Aarvak T, Vemuri MC.

J Immunol Res. 2016;2016:5474602. doi: 10.1155/2016/5474602. Epub 2016 May 19. Review.

2.

Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS Immune Cell Serum Replacement.

Smith C, Økern G, Rehan S, Beagley L, Lee SK, Aarvak T, Schjetne KW, Khanna R.

Clin Transl Immunology. 2015 Jan 16;4(1):e31. doi: 10.1038/cti.2014.31. eCollection 2015 Jan.

3.

Temporal increase in mtDNA diversity in a declining population.

Ruokonen M, Aarvak T, Chesser RK, Lundqvist AC, Merilä J.

Mol Ecol. 2010 Jun 1;19(12):2408-17. doi: 10.1111/j.1365-294X.2010.04653.x. Epub 2010 May 21.

PMID:
20497326
4.

Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy.

Rasmussen AM, Borelli G, Hoel HJ, Lislerud K, Gaudernack G, Kvalheim G, Aarvak T.

J Immunol Methods. 2010 Apr 15;355(1-2):52-60. doi: 10.1016/j.jim.2010.02.004. Epub 2010 Feb 19.

PMID:
20171968
5.

Taxonomy of the bean goose-pink-footed goose.

Ruokonen M, Litvin K, Aarvak T.

Mol Phylogenet Evol. 2008 Aug;48(2):554-62. doi: 10.1016/j.ympev.2008.04.038. Epub 2008 May 3.

PMID:
18550388
6.

Cell isolation and expansion using Dynabeads.

Neurauter AA, Bonyhadi M, Lien E, Nøkleby L, Ruud E, Camacho S, Aarvak T.

Adv Biochem Eng Biotechnol. 2007;106:41-73. Review.

PMID:
17680228
7.

Colonization history of the high-arctic pink-footed goose Anser brachyrhynchus.

Ruokonen M, Aarvak T, Madsen J.

Mol Ecol. 2005 Jan;14(1):171-8.

PMID:
15643960
8.

The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissue.

Shadidi KR, Aarvak T, Henriksen JE, Natvig JB, Thompson KM.

Scand J Immunol. 2003 Feb;57(2):192-8.

9.

A mouse C kappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation.

Schjetne KW, Thompson KM, Aarvak T, Fleckenstein B, Sollid LM, Bogen B.

Int Immunol. 2002 Dec;14(12):1423-30.

PMID:
12456590
10.

Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis.

Shadidi KR, Thompson KM, Henriksen JE, Natvig JB, Aarvak T.

Scand J Immunol. 2002 Mar;55(3):274-83.

11.

T-cell responses to viral, bacterial and protozoan antigens in rheumatoid inflammation. Selective migration of T cells to synovial tissue.

Shadidi KR, Aarvak T, Jeansson S, Henriksen JE, Natvig JB, Thompson KM.

Rheumatology (Oxford). 2001 Oct;40(10):1120-5.

PMID:
11600741
12.

Switch in chemokine receptor phenotype on memory T cells without a change in the cytokine phenotype.

Aarvak T, Strand E, Teigland J, Miossec P, Natvig JB.

Scand J Immunol. 2001 Jul-Aug;54(1-2):100-8.

13.
14.
15.

Changes in the Th1 or Th2 cytokine dominance in the synovium of rheumatoid arthritis (RA): a kinetic study of the Th subsets in one unusual RA patient.

Aarvak T, Chabaud M, Thoen J, Miossec P, Natvig JB.

Rheumatology (Oxford). 2000 May;39(5):513-22.

PMID:
10852982
16.

Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium.

Aarvak T, Chabaud M, Källberg E, Miossec P, Natvig JB.

Scand J Immunol. 1999 Jul;50(1):1-9.

17.
18.

IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells.

Aarvak T, Chabaud M, Miossec P, Natvig JB.

J Immunol. 1999 Feb 1;162(3):1246-51.

Supplemental Content

Loading ...
Support Center